SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MEMPHASYS LIMITED (MEM)

Listed on ASX

SHARE PRICES

Former (or subsequent) names

 FROMTO
MEMPHASYS LIMITED06/07/2016
NUSEP HOLDINGS LTD04/11/201006/07/2016
NUSEP LTD04/11/2010

Shareholder links

Our website ranking of MEM: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MEM5
Address: 30 Richmond Road Homebush, NSW 2140
Tel:  +61 2 8415 7300 Fax: 

Date first listed: 14/05/2007
Company Secretary: Andrew Metcalfe
Sector: Pharmaceuticals Biotechnology & Life Sciences Industry Group: XHJ
Activities: Memphasys Limited (ASX:MEM) specialises in biological separations for commercial applications. The Company's patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained

we understand that on or about this date the company consolidated its shares 1 for 15

17/08/2018

name changed from Nusep Holdings Ltd

06/07/2016

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    29/03/2019Andrew Goodall496,843$0.020$9,937
    27/09/2018Marjan Mikel1,000,000$0.012$12,000
    26/09/2018Andrew Goodall1,000,000$0.012$12,000
    26/09/2018Marjan Mikel650,000$0.014$9,079
    19/09/2018Marjan Mikel2,000,000$0.014$28,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Alison CouttsExecutive Chairman, Deputy CEO29/11/2013
    Paul WrightIndependent Director13/03/2020
    Andrew GoodallNon Exec Director14/03/2012
    Shane HartwigNon Exec Director31/07/2019
    Tom RoweGeneral Counsel07/11/2011

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Marjan MikelIndependent Director07/06/201813/03/2020
    John PereiraIndependent Director30/08/201607/06/2018
    Robert GilmourNon Exec Director12/04/201629/09/2016
    Mark GellIndependent Director17/10/201412/04/2016
    Michael GrahamNon Exec Director10/09/201404/01/2016
    Stephen van der MyeNon Exec Director02/12/201328/04/2014
    Prakash PatelDirector, CEO01/12/201210/02/2014
    John ManusuNon Exec Chairman11/09/200629/11/2013
    Hari NairDeputy Chairman, Non Exec Director11/09/200629/11/2013
    Chenicheri NairManaging Director, CEO11/09/200629/11/2013
    Clifford EuNon Exec Director01/12/201229/11/2013
    Iain SorrellDirector11/09/200630/11/2012
    Ward WescottDirector10/10/201130/11/2012
    David RoffeDirector10/10/201130/11/2012
    William SpeeDirector01/07/200919/03/2012
    John O'ConnorDirector10/10/201119/02/2012

    Date of first appointment, title may have changed.